With a $1 billion buyout offer on the table, Summerlin’s developer could undergo another corporate shakeup.
A new study has uncovered the mystery behind why Huntington's disease strikes later in life, despite the genetic mutation ...
Federal health officials are backing the health benefits of nicotine pouches, ruling that Philip Morris International’s Zyn ...